Knauer et al., 2003 - Google Patents
In-vitro response of Plasmodium falciparum to the main alkaloids of Cinchona in northwestern Thailand.Knauer et al., 2003
- Document ID
- 10265333090789566348
- Author
- Knauer A
- Sirichaisinthop J
- Reinthaler F
- Wiedermann G
- Wernsdorfer G
- Wernsdorfer W
- Publication year
- Publication venue
- Wiener Klinische Wochenschrift
External Links
Snippet
The blood schizontocidal activity of the four main Cinchona alkaloids against Plasmodium falciparum was compared in 46 fresh parasite isolates, using an in-vitro test measuring the drug-specific inhibition of schizont maturation. The studies were conducted in June-August …
- 241000223960 Plasmodium falciparum 0 title abstract description 34
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pollack et al. | The effect of ascaridole on the in vitro development of Plasmodium falciparum | |
| Levy et al. | Babesia bovis: continuous cultivation in a microaerophilous stationary phase culture | |
| Gathirwa et al. | The in vitro anti-plasmodial and in vivo anti-malarial efficacy of combinations of some medicinal plants used traditionally for treatment of malaria by the Meru community in Kenya | |
| Day et al. | The biology of Plasmodium falciparum transmission stages | |
| US8506973B2 (en) | Injectable anticancer composition for local administration containing hydroxychloroquine | |
| Giannini et al. | Treatment of khat addiction | |
| Boakye-Yiadom | Antimicrobial properties of some West African medicinal plants II. Antimicrobial activity of aqueous extracts of Cryptolepis sanguinolenta (Lindl.) Schlechter | |
| Rukunga et al. | The antiplasmodial activity of spermine alkaloids isolated from Albizia gummifera | |
| Kawai et al. | Morphologic effects of artemether on Plasmodium falciparum in Aotus trivirgatus | |
| EP0362810A1 (en) | Antimalarial compositions using quinidine, artemisinine and its derivatives | |
| Gysin et al. | Experimental Plasmodium falciparum cerebral malaria in the squirrel monkey Saimiri sciureus | |
| Knauer et al. | In-vitro response of Plasmodium falciparum to the main alkaloids of Cinchona in northwestern Thailand. | |
| Li | Hallucinogenic plants in Chinese herbals | |
| Joyner et al. | Further observations on the genetic transfer of drug resistance in Eimeria maxima | |
| Gupta et al. | Berberine in the treatment of oriental sore | |
| Leighton | Botulism and food preservation:(The Loch Maree tragedy) | |
| Verdrager et al. | Chloroquine-resistant Falciparum malaria in East Kalimantan, Indonesia J. Verdrager...[et al.] | |
| Tripathi et al. | Sodium β-artelinate—A new potential gametocytocide | |
| Korzeniewski et al. | Travel medicine for divers | |
| Salako et al. | Evaluation of the sensitivity in vivo and in vitro of Plasmodium falciparum malaria to quinine in an area of full sensitivity to chloroquine | |
| Rees et al. | Transmisjsion of human leprosy to the mouse and its clinical implications | |
| Murphy et al. | Continuation of chloroquine-susceptible Plasmodium falciparum parasitemia in volunteers receiving chloroquine therapy | |
| Kyavar et al. | In vitro interaction between artemisinin and chloroquine as well as desbutyl-benflumetol in Plasmodium vivax | |
| Masaba et al. | Sensitivity of Plasmodium falciparum to chloroquine in Busia District, Kenya | |
| Ayogu et al. | Evaluation of ciprofloxacin effect on the antimalarial activity of some antimalarial drugs in plasmodium Berghei infected mice |